Epilepsy, a chronic neurological disorder characterized by recurrent seizures, affects around 50 million people worldwide. Despite the availability of numerous antiepileptic drugs (AEDs), around one-third of patients continue to experience seizures. This necessitates continuous research and development in this field. This article aims to provide an overview of the recent advancements in epilepsy management.
Several new AEDs have been introduced in recent years, including brivaracetam, cenobamate, and perampanel. These drugs, with their unique mechanisms of action, offer improved seizure control, fewer side effects, and better patient compliance compared to traditional AEDs. They can be used alone or in combination with other drugs, providing new therapeutic options for patients with drug-resistant epilepsy.
Surgical intervention is considered for patients who do not respond to medical therapy. Recent advancements in neuroimaging and surgical techniques, such as stereotactic laser ablation and responsive neurostimulation, have improved the precision and safety of epilepsy surgery. These minimally invasive procedures offer promising outcomes with reduced postoperative complications.
Genetic testing has become increasingly important in the diagnosis and management of epilepsy. Identification of specific genetic mutations can help in predicting disease prognosis, guiding treatment decisions, and providing genetic counseling. Moreover, ongoing research in gene therapy holds the potential for a cure in certain genetic forms of epilepsy.
The COVID-19 pandemic has accelerated the adoption of telemedicine in epilepsy care. Virtual visits, remote monitoring of seizures, and digital cognitive assessments have proven effective in providing continuous care to patients, reducing the need for hospital visits, and improving patient satisfaction.
Recent advances in epilepsy management have significantly improved the quality of life for patients. Continuous research and innovation in this field hold the promise of further advancements, potentially leading to more effective treatments and even a cure for this debilitating condition.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation